MLL translocations, histone modifications and leukaemia stem-cell development

AV Krivtsov, SA Armstrong - Nature reviews cancer, 2007 - nature.com
AV Krivtsov, SA Armstrong
Nature reviews cancer, 2007nature.com
Translocations that involve the mixed lineage leukaemia (MLL) gene identify a unique group
of acute leukaemias, and often predict a poor prognosis. The MLL gene encodes a DNA-
binding protein that methylates histone H3 lysine 4 (H3K4), and positively regulates gene
expression including multiple Hox genes. Leukaemogenic MLL translocations encode MLL
fusion proteins that have lost H3K4 methyltransferase activity. A key feature of MLL fusion
proteins is their ability to efficiently transform haematopoietic cells into leukaemia stem cells …
Abstract
Translocations that involve the mixed lineage leukaemia (MLL) gene identify a unique group of acute leukaemias, and often predict a poor prognosis. The MLL gene encodes a DNA-binding protein that methylates histone H3 lysine 4 (H3K4), and positively regulates gene expression including multiple Hox genes. Leukaemogenic MLL translocations encode MLL fusion proteins that have lost H3K4 methyltransferase activity. A key feature of MLL fusion proteins is their ability to efficiently transform haematopoietic cells into leukaemia stem cells. The link between a chromatin modulator and leukaemia stem cells provides support for epigenetic landscapes as an important part of leukaemia and normal stem-cell development.
nature.com